## EG: Everest Group, Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.0% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($323.28)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. Q3 Earnings Highs And Lows: Everest Group (NYSE:EG) Vs The Rest Of The Reinsurance Stocks**
- Source: Yahoo Finance | 20251231T030744 | Somewhat-Bearish | Relevance: 97%
- This article compares the Q3 2025 earnings performance of several reinsurance stocks, highlighting Everest Group (NYSE:EG) as the weakest and Hamilton Insurance Group (NYSE:HG) as the strongest performer. It notes that the reinsurance sector is cyclical and influenced by a "hard market" of strong premium rates, interest rates, and the impact of climate change on catastrophe losses. The article also provides a general market update, discussing inflation, interest rate cuts, and the post-election stock market surge.

**2. JB Capital LLC Invests $3.37 Million in Everest Group, Ltd. $EG**
- Source: MarketBeat | 20251231T131514 | Neutral | Relevance: 96%
- JB Capital LLC has invested $3.37 million in Everest Group, acquiring 9,622 shares. Several other institutional investors also adjusted their holdings in Everest Group. The company recently reported an EPS miss of $7.54 against an expected $13.39, but revenue exceeded estimates at $4.32 billion.

**3. AXS Stock Moves Above 50 & 200-Day SMA: Buy, Sell or Stay Invested?**
- Source: www.sharewise.com | 20260102T180914 | Somewhat-Bearish | Relevance: 69%
- Shares of Axis Capital Holdings (AXS) have shown a bullish trend, trading above their 50-day and 200-day simple moving averages, indicating potential for continued growth. The company, a global specialty insurer, is noted for its diversified product portfolio, underwriting excellence, and strong capital position, contributing to its 20.5% gain over the past year. Despite muted analyst sentiment regarding near-term earnings, AXS is considered undervalued compared to its industry, offering consistent dividend growth and robust profitability metrics.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $359 | $0 | 0% |
| 2025-12-15 | TD Cowen | $365 | $400 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |
| 2025-12-15 | TD Cowen | main | Hold |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (-1.0%)
- Blackrock Inc.: 8.1% (-2.9%)
- AQR Capital Manageme: 4.8% (+70.3%)
- State Street Corpora: 4.5% (-0.7%)
- Vulcan Value Partner: 3.4% (+13.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Forward P/E 6.0x attractive for 24% earnings growth. Balance sheet: strong liquidity (11.3x). Revenue declining -7% YoY, concerning. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (3 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.0B |
| Beta | 0.38 |
| 52W Range | $302.44 - $373.23 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -50.00 |
| Forward P/E | 6.0 |
| Current P/E | 7.5 |
| YoY Growth | 24.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 0.0% (minimal 5-day change). Below STRENGTH zone by 3.0pp (needs >3.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (1.12), confirming momentum. RSI neutral at 58. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.04% (CS: 36) | Neutral |
| RSI_14 | 57.5 | Neutral |
| MACD Histogram | 1.12 | Bullish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 0.988x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $334.48
- **Stop Loss:** $323.28 (3.3% risk)
- **Target:** $345.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 128
- **Position Value:** $42,813.44
- **Portfolio %:** 42.81%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-02 (Est: $13.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $14.52 | $7.54 | -48.1% |
| 2025Q2 | $14.82 | $17.36 | +17.1% |
| 2025Q1 | $7.74 | $6.45 | -16.7% |
| 2024Q4 | $-17.42 | $-18.39 | -5.6% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*